Wearable Health Solutions, Inc. (WHSI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -2.26 Million USD | 82.4% |
| 2022 | -12.96 Million USD | -304.33% |
| 2021 | -3.09 Million USD | -320.73% |
| 2020 | -1.05 Million USD | -3036.55% |
| 2019 | -427.15 Thousand USD | 89.4% |
| 2018 | -226.48 Thousand USD | 93.94% |
| 2017 | -3.53 Million USD | -542.65% |
| 2016 | -593.7 Thousand USD | -33.48% |
| 2015 | 1.02 Million USD | 56.1% |
| 2014 | 520.33 Thousand USD | -51.21% |
| 2013 | 3.84 Million USD | 76.47% |
| 2012 | -9.58 Million USD | -174.19% |
| 2011 | -1.01 Million USD | -325.15% |
| 2010 | -3.54 Million USD | 78.72% |
| 2009 | -1.13 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -332.44 Thousand USD | 112.23% |
| 2024 Q2 | -68.41 Thousand USD | 163.5% |
| 2023 FY | - USD | 82.4% |
| 2023 Q1 | -736.48 Thousand USD | 21.91% |
| 2023 Q2 | -516.14 Thousand USD | 29.92% |
| 2023 Q3 | -476.35 Thousand USD | 7.71% |
| 2023 Q4 | -531.76 Thousand USD | -11.63% |
| 2022 Q3 | -7.35 Million USD | -1543.24% |
| 2022 FY | - USD | -304.33% |
| 2022 Q1 | -4.09 Million USD | -471.76% |
| 2022 Q2 | -447.68 Thousand USD | 89.07% |
| 2022 Q4 | -943.07 Thousand USD | 87.18% |
| 2021 Q2 | -416.87 Thousand USD | -61.88% |
| 2021 FY | - USD | -320.73% |
| 2021 Q3 | -207.95 Thousand USD | 50.12% |
| 2021 Q4 | -716.42 Thousand USD | -244.52% |
| 2021 Q1 | -257.51 Thousand USD | 55.74% |
| 2020 Q4 | -581.8 Thousand USD | -383.1% |
| 2020 FY | - USD | -3036.55% |
| 2020 Q3 | -120.43 Thousand USD | -196.32% |
| 2020 Q2 | -40.64 Thousand USD | -235.33% |
| 2020 Q1 | -12.12 Thousand USD | 49.65% |
| 2019 Q4 | -24.07 Thousand USD | 54.2% |
| 2019 Q1 | -15.36 Thousand USD | -151.4% |
| 2019 Q2 | -67.86 Thousand USD | -341.78% |
| 2019 Q3 | -52.56 Thousand USD | 22.55% |
| 2019 FY | - USD | 89.4% |
| 2018 Q3 | 170.25 Thousand USD | 172.37% |
| 2018 FY | - USD | 93.94% |
| 2018 Q4 | 29.88 Thousand USD | -82.44% |
| 2018 Q2 | -235.25 Thousand USD | -22.61% |
| 2018 Q1 | -191.87 Thousand USD | -286.09% |
| 2017 Q1 | -3.66 Million USD | -1561.96% |
| 2017 Q2 | -127.36 Thousand USD | 96.52% |
| 2017 Q3 | -57.15 Thousand USD | 55.12% |
| 2017 Q4 | 103.1 Thousand USD | 280.39% |
| 2017 FY | - USD | -542.65% |
| 2016 Q3 | -190.03 Thousand USD | -977.93% |
| 2016 Q4 | -220.48 Thousand USD | -16.02% |
| 2016 FY | - USD | -33.48% |
| 2016 Q1 | -158.98 Thousand USD | 31.3% |
| 2016 Q2 | -17.63 Thousand USD | 88.91% |
| 2015 Q1 | 15.04 Thousand USD | -48.61% |
| 2015 Q2 | -61.9 Thousand USD | -511.6% |
| 2015 Q3 | -158.41 Thousand USD | -155.9% |
| 2015 Q4 | -231.4 Thousand USD | -46.08% |
| 2015 FY | - USD | 56.1% |
| 2014 Q1 | 28.04 Thousand USD | 107.41% |
| 2014 Q4 | 29.26 Thousand USD | 167.69% |
| 2014 Q2 | -1 Million USD | -3696.41% |
| 2014 FY | - USD | -51.21% |
| 2014 Q3 | -43.23 Thousand USD | 95.71% |
| 2013 Q3 | -92.49 Thousand USD | -11.6% |
| 2013 Q2 | -82.87 Thousand USD | 24.28% |
| 2013 Q1 | -109.45 Thousand USD | 95.14% |
| 2013 FY | - USD | 76.47% |
| 2013 Q4 | -378.47 Thousand USD | -309.2% |
| 2012 Q3 | -229.47 Thousand USD | -572.77% |
| 2012 Q2 | -34.1 Thousand USD | 87.73% |
| 2012 Q4 | -2.25 Million USD | -882.34% |
| 2012 FY | - USD | -174.19% |
| 2012 Q1 | -277.96 Thousand USD | -30.34% |
| 2011 Q4 | -213.26 Thousand USD | -516.68% |
| 2011 FY | - USD | -325.15% |
| 2011 Q3 | -34.58 Thousand USD | 93.54% |
| 2011 Q2 | -535.52 Thousand USD | 8.06% |
| 2011 Q1 | -582.43 Thousand USD | -175.6% |
| 2010 Q2 | -1.09 Million USD | -194.32% |
| 2010 FY | - USD | 78.72% |
| 2010 Q4 | 770.41 Thousand USD | 104.22% |
| 2010 Q3 | -18.23 Million USD | -1564.54% |
| 2010 Q1 | -372.22 Thousand USD | -9.61% |
| 2009 Q1 | -280.28 Thousand USD | 0.0% |
| 2009 Q4 | -339.59 Thousand USD | -695.3% |
| 2009 Q2 | -253.39 Thousand USD | 9.59% |
| 2009 FY | - USD | 0.0% |
| 2009 Q3 | -42.7 Thousand USD | 83.15% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | -134.527% |
| Ansell Limited | 209.86 Million USD | 101.077% |
| Ansell Limited | 206.3 Million USD | 101.096% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 42.83 Million USD | 105.277% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.62 Million USD | -39.126% |
| Psykey, Inc. | -1.29 Million USD | -74.533% |
| ConvaTec Group Plc | 455.5 Million USD | 100.496% |
| ConvaTec Group Plc | 455.5 Million USD | 100.496% |
| Encision Inc. | -544.19 Thousand USD | -315.428% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -1494.201% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | -1956.523% |
| Innovative MedTech Inc. | -7.67 Million USD | 70.54% |
| LifePoint, Inc. | -14.2 Million USD | 84.082% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 63.46% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | -595.611% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | -950.362% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | -457.128% |
| SmileDirectClub, Inc. | -186.13 Million USD | 98.785% |
| Sector 10, Inc. | - USD | Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | 100.505% |
| SheerVision, Inc. | -110.53 Thousand USD | -1945.341% |
| United Health Products, Inc. | -2.5 Million USD | 9.651% |
| Vasamed, Inc. | -4.57 Million USD | 50.579% |
| Yubo International Biotech Limited | -1.17 Million USD | -91.964% |